Kingdom Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$174K Buy
150
+128
+582% +$151K 0.04% 157
2026
Q2
$26.6K Sell
22
-298
-93% -$304K 0.01% 341
2026
Q1
$294K Buy
320
+34
+12% +$34.5K 0.08% 114
2025
Q4
$307K Sell
286
-360
-56% -$344K 0.1% 108
2025
Q3
$492K Buy
+646
New +$481K 0.3% 49
2024
Q1
– Sell
-571
Closed -$333K – 80
2023
Q4
$333K Buy
571
+102
+22% +$59.5K 0.29% 56
2023
Q3
$252K Sell
469
-24
-5% -$12.4K 0.24% 61
2023
Q2
$231K Buy
+493
New +$207K 0.23% 56

Other funds holding LLY

Kingdom Financial Group's LLY Position: Q3 2026 in Review

Kingdom Financial Group increased its Eli Lilly (LLY) stake by 582% in Q3 2026, buying an estimated $151K and bringing the position to 150 shares worth $174K. The position accounts for 0.04% of the portfolio, ranked #157.

Kingdom Financial Group first reported a position in LLY in Q2 2023 and has held it in 8 quarters since. The position peaked at $492K in Q3 2025. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Kingdom Financial Group held 150 shares of Eli Lilly worth $174K as of Q3 2026.
  • Kingdom Financial Group bought 128 Eli Lilly shares in Q3 2026, an estimated $151K.
  • Eli Lilly made up 0.04% of Kingdom Financial Group's portfolio in Q3 2026, its #157 holding.
  • Kingdom Financial Group first reported a position in Eli Lilly in Q2 2023 and has held it in 8 quarters since.
  • Kingdom Financial Group's Eli Lilly position peaked at $492K in Q3 2025.
  • 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Kingdom Financial Group's 13F filing for Q3 2026, filed 4 Nov 2026.